Company news

iRhythm Holdings, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

September 3, 2024

iRhythm Technologies Announces Results of GUARD-AF Trial

August 31, 2024

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

August 28, 2024

iRhythm Technologies to Participate in Upcoming Investor Conferences in September

August 20, 2024

iRhythm Technologies Announces Second Quarter 2024 Financial Results

July 31, 2024

iRhythm Technologies Announces Chief Financial Officer Transition

July 31, 2024

iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024

July 17, 2024

iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation

June 16, 2024

iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference

June 3, 2024

iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference

May 21, 2024

iRhythm Technologies Announces First Quarter 2024 Financial Results

May 1, 2024

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

April 17, 2024

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes

March 7, 2024

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029

March 3, 2024

iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes

March 3, 2024

iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients

February 28, 2024

iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results

February 21, 2024

iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

February 7, 2024

iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference

January 7, 2024

Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service

January 4, 2024

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System

January 2, 2024

iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 25, 2023

New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization

November 12, 2023

iRhythm Technologies Announces Third Quarter 2023 Financial Results

November 1, 2023

iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023

October 18, 2023

iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor

September 25, 2023

iRhythm Technologies to Participate in Two Investor Conferences in September

August 28, 2023

Zio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and Welfare

August 2, 2023

iRhythm Technologies Announces Second Quarter 2023 Financial Results

August 2, 2023

iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023

July 19, 2023

NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and Payers

July 17, 2023

iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments

June 5, 2023

iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference

May 23, 2023

New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

May 21, 2023

iRhythm Technologies Announces First Quarter 2023 Financial Results

May 3, 2023

iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023

April 19, 2023

iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth

April 11, 2023

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors

March 5, 2023

Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC

March 1, 2023

iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results

February 22, 2023

iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

February 8, 2023

iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference

January 8, 2023

iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 26, 2022

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

November 6, 2022

New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective

November 5, 2022

iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023

November 1, 2022

iRhythm Technologies Announces Third Quarter 2022 Financial Results

October 31, 2022

iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022

October 19, 2022

iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day

September 20, 2022

iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022

August 30, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 25 decks. Every deck is listed under its year.